Form 4: Medtronic CEO Martha Geoffrey Reports Share Withholding
Statement of Changes in Beneficial Ownership
Medtronic Chairman and CEO Martha Geoffrey reported the withholding of 41,936 shares to cover tax obligations related to vested restricted stock units.
Summary
- Chairman and CEO Martha Geoffrey disposed of 41,936 ordinary shares of Medtronic plc.
- The transaction occurred on June 4, 2026, at a price of $83.32 per share.
- The disposal was a mandatory tax withholding event following the vesting of performance-based restricted stock units on April 24, 2026.
- Following this transaction, the reporting person maintains a direct beneficial ownership of 301,163 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative tax settlement rather than a strategic shift or discretionary divestment.
Positives
- The transaction was a routine tax-related withholding rather than a discretionary open-market sale.
- The CEO retains a significant equity stake of 301,163 shares, aligning interests with shareholders.
Negatives
- The transaction results in a reduction of the CEO's direct shareholding.
Risks
- None identified; this is a standard administrative compliance filing.
Future Outlook
Not applicable as this is a retrospective disclosure of a completed transaction.
Industry Context
StockSavvy.ai notes that tax-related share withholding is a standard practice for executives in large-cap medical device companies like Medtronic, reflecting the settlement of long-term incentive plans rather than a change in market sentiment.
Comparison to Industry Standards
- The transaction aligns with standard executive compensation practices at peer companies such as Abbott Laboratories and Boston Scientific, where equity-based compensation is a primary component of executive pay.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was a non-discretionary tax withholding.
Next Steps
- None
Key Dates
| Date | Description |
|---|---|
| 04/24/2026 | Vesting date of performance-vesting restricted stock units. |
| 06/04/2026 | Transaction date for tax withholding. |
| 06/08/2026 | Date of filing. |
Keywords
Medtronic, MDT, Insider Trading, Form 4, Executive Compensation, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.